Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug eruptions/etiology"" wg kryterium: Temat


Tytuł :
Linezolid versus vancomycin for skin and soft tissue infections.
Autorzy :
Yue J; Department of Geriatrics,West China Hospital, Sichuan University, Chengdu, China.
Dong BR
Yang M
Chen X
Wu T
Liu GJ
Pokaż więcej
Źródło :
Evidence-based child health : a Cochrane review journal [Evid Based Child Health] 2014 Mar; Vol. 9 (1), pp. 103-66.
Typ publikacji :
Journal Article
Journal Info :
Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101296879 Publication Model: Print Cited Medium: Internet ISSN: 1557-6272 (Electronic) Linking ISSN: 15576272 NLM ISO Abbreviation: Evid Based Child Health Subsets: PubMed not MEDLINE
Czasopismo naukowe
Tytuł :
Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab.
Index Terms :
Sciences bio-médicales et agricoles
Administration, Cutaneous
Angiogenesis Inhibitors -- adverse effects
Antineoplastic Agents -- adverse effects
Bevacizumab -- adverse effects
Drug Eruptions -- etiology
Drug-Related Side Effects and Adverse Reactions
Humans
Indoles -- adverse effects
Niacinamide -- adverse effects -- analogs & derivatives
Phenylurea Compounds -- adverse effects
Pyrroles -- adverse effects
Angiogenesis
Angiogénesis
Antiangiogenic agents
Antiangiogénesis
Bevacizumab
Cutaneous adverse effects
Efectos cutáneos adversos
Sorafenib
Sunitinib
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265075">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265075
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
A comedonal acneiform eruption following dovitinib therapy.
Index Terms :
Sciences bio-médicales et agricoles
Acneiform Eruptions -- chemically induced
Antineoplastic Agents -- adverse effects
Benzimidazoles -- adverse effects
Drug Eruptions -- etiology
Humans
Male
Middle Aged
Protein Kinase Inhibitors -- adverse effects
Quinolones -- adverse effects
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265059">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265059
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Reply to C. Fontanella et al
Index Terms :
Généralités
Antibodies, Monoclonal, Humanized -- adverse effects
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Diarrhea -- chemically induced
Drug Eruptions -- etiology
Drug-Induced Liver Injury -- etiology
Female
Humans
Neoadjuvant Therapy -- methods
Quinazolines -- adverse effects
info:eu-repo/semantics/article
info:ulb-repo/semantics/articleLetterToEditor
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/193296">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/193296
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Index Terms :
Sciences bio-médicales et agricoles
Adenocarcinoma -- drug therapy -- genetics -- pathology -- surgery
Adult
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Chemotherapy, Adjuvant
Colonic Neoplasms -- drug therapy -- genetics -- pathology -- surgery
Diarrhea -- chemically induced
Disease-Free Survival
Drug Eruptions -- etiology
Exons -- genetics
Female
Fluorouracil -- adverse effects -- therapeutic use
Humans
Infusions, Intravenous -- adverse effects
Intention to Treat Analysis
Leucovorin -- adverse effects -- therapeutic use
Male
Middle Aged
Mucositis -- chemically induced
Neoplasm Staging
Organoplatinum Compounds -- adverse effects -- therapeutic use
Proto-Oncogene Proteins -- genetics
ras Proteins -- genetics
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/186439">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/186439
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy
Index Terms :
Néphrologie - urologie
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects -- pharmacokinetics
Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics
Bone Neoplasms -- blood -- drug therapy -- secondary
Disease-Free Survival
Drug Eruptions -- etiology
Humans
Integrin alphaV -- immunology
Male
Middle Aged
Pain Measurement
Prostate-Specific Antigen -- blood
Prostatic Neoplasms, Castration-Resistant -- blood -- drug therapy -- pathology
Sepsis -- chemically induced
gamma-Glutamyltransferase -- blood
Castrate-resistant prostate cancer (CRPC)
EMD 525797
αv-Integrin overexpression
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168906">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168906
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
Index Terms :
Cancérologie
Adult
Age Factors
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Agents -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Breast Neoplasms -- chemistry -- drug therapy -- pathology
Chemotherapy, Adjuvant
Diarrhea -- chemically induced
Drug Administration Schedule
Drug Eruptions -- etiology
Drug-Induced Liver Injury -- etiology
Female
Humans
Incidence
Logistic Models
Middle Aged
Neoadjuvant Therapy -- methods
Paclitaxel -- administration & dosage
Quinazolines -- administration & dosage -- adverse effects
Receptor, ErbB-2 -- analysis
Time Factors
Tumor Markers, Biological -- analysis
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/193279">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/193279
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies